Deal Library / Pharma BD Deal Intelligence

Astellas Pharma Inc. — Pharma Deals

The Pharma Closeout tracks 11 deals, $15.2B in disclosed deal value, 10 with a post-close Outcome Score for Astellas Pharma Inc..

Median Critic Score: 83 · Median Outcome Score: 40

All 11 deals

Astellas Pharma Inc. / Seagen Inc. — 2009 · $4.5B · Worked — the deal delivered on its rationale.
Astellas Pharma Inc. / Ganymed Pharmaceuticals — 2016 · $1.4B · Worked — the deal delivered on its rationale.
Astellas Pharma Inc. / Sangamo Therapeutics, Inc. — 2026 · $50M · Largely worked — most objectives met.
Astellas Pharma Inc. / Ogeda SA — 2017 · $850M · Mixed — partial payoff, real shortfalls.
Astellas Pharma Inc. / Ocata Therapeutics, Inc. — 2015 · $379M · Underwhelmed — fell short of the thesis.
Astellas Pharma Inc. / Optimer Pharmaceuticals, Inc. — 2012 · $90M · Underwhelmed — fell short of the thesis.
Astellas Pharma Inc. / OSI Pharmaceuticals, Inc. — 2010 · $4.0B · Underwhelmed — fell short of the thesis.
Astellas Pharma Inc. / Audentes Therapeutics — 2019 · $3.0B · Did not work — the deal failed to deliver.
Astellas Pharma Inc. / Mitobridge, Inc. — 2018 · $450M · Did not work — the deal failed to deliver.
Astellas Pharma Inc. / Maxygen, Inc. (Perseid Therapeutics stake) — 2011 · $76M · Did not work — the deal failed to deliver.
Astellas Pharma Inc. / Potenza Therapeutics, Inc. — 2019 · $405M